JORGE L GARCIA

Allopathic & Osteopathic Physicians|General Practice MIAMI, FL NPI 1023219763

General Payments — all program years on this page

$4,335.44

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 13
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,306.88 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $3,060.001
Travel and Lodging $985.486
Food and Beverage $261.405

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Alnylam Pharmaceuticals Inc. $4,140.3710
Coherus Biosciences Inc. $142.271
Novo Nordisk AS $24.241

By program year

Program yearAmountRecords
2019 $28.561
2024 $4,306.8812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097409274 Novo Nordisk Inc $24.24 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125829767 Alnylam Pharmaceuticals Inc. $29.30 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125829769 Alnylam Pharmaceuticals Inc. $49.00 10/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125829771 Alnylam Pharmaceuticals Inc. $74.80 10/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125829773 Alnylam Pharmaceuticals Inc. $44.15 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125829775 Alnylam Pharmaceuticals Inc. $6.56 10/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125829777 Alnylam Pharmaceuticals Inc. $63.51 10/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125829779 Alnylam Pharmaceuticals Inc. $21.44 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125829781 Alnylam Pharmaceuticals Inc. $3,060.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125829783 Alnylam Pharmaceuticals Inc. $403.96 10/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125829785 Alnylam Pharmaceuticals Inc. $387.65 10/21/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147277564 Coherus Biosciences Inc. $142.27 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.